Darrell & King’s Pfizer PFE Stock Holding History

Darrell & King’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$368K	Sell	10,000 -540	-5%	-$19.8K	0.06%	29
2020 Q3	$367K	Hold	10,540	–	–	0.08%	26
2020 Q2	$327K	Hold	10,540	–	–	0.06%	31
2020 Q1	$326K	Buy	+10,540	New	+$359K	0.08%	30
2019 Q3	$359K	Hold	10,540	–	–	0.07%	36
2019 Q2	$433K	Hold	10,540	–	–	0.09%	30
2019 Q1	$425K	Hold	10,540	–	–	0.07%	33
2018 Q4	$436K	Hold	10,540	–	–	0.08%	33
2018 Q3	$441K	Sell	10,540 -53	-0.5%	-$2.04K	0.06%	34
2018 Q2	$365K	Buy	10,593 +53	+0.5%	+$1.81K	0.05%	37
2018 Q1	$355K	Hold	10,540	–	–	0.05%	38
2017 Q4	$362K	Hold	10,540	–	–	0.05%	38
2017 Q3	$357K	Hold	10,540	–	–	0.05%	39
2017 Q2	$336K	Sell	10,540 -422	-4%	-$13.3K	0.05%	39
2017 Q1	$356K	Buy	10,962 +422	+4%	+$13.3K	0.06%	39
2016 Q4	$325K	Sell	10,540 -5,850	-36%	-$179K	0.05%	39
2016 Q3	$527K	Hold	16,390	–	–	0.09%	30
2016 Q2	$548K	Sell	16,390 -2,022	-11%	-$64.5K	0.1%	28
2016 Q1	$518K	Sell	18,412 -86	-0.5%	-$2.46K	0.1%	29
2015 Q4	$567K	Buy	+18,498	New	+$582K	0.09%	33

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Darrell & King's PFE Position: Q4 2020 in Review

Darrell & King reduced its Pfizer (PFE) stake by 5.1% in Q4 2020, selling an estimated $19.8K and leaving 10,000 shares worth $368K. The position accounts for 0.06% of the portfolio, ranked #29.

Darrell & King first reported a position in PFE in Q4 2015 and has held it in 20 quarters since. The position peaked at $567K in Q4 2015. 2,675 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Darrell & King held 10,000 shares of Pfizer worth $368K as of Q4 2020.
Darrell & King sold 540 Pfizer shares in Q4 2020, an estimated $19.8K.
Pfizer made up 0.06% of Darrell & King's portfolio in Q4 2020, its #29 holding.
Darrell & King first reported a position in Pfizer in Q4 2015 and has held it in 20 quarters since.
Darrell & King's Pfizer position peaked at $567K in Q4 2015.
2,675 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Darrell & King's 13F filing for Q4 2020, filed 15 Jan 2021.